Patent · US Active

Method and medicament for inhibiting the expression of a given gene

US8729037B2 · kind B2 · utility

0Cited by
84References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 31, 2007
Grant dateMay 20, 2014
Priority date
Expiry dateAug 29, 2029

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the specific inhibition of expression of a target gene in mammals using a short double stranded RNA. The dsRNA is less than 49 nucleotides in length and has a nucleotide sequence which is complementary to at least a part of the target gene. The dsRNAs of the present invention are useful for treating diseases, for example, cancer, viral diseases or neurodegenerative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.